Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Actual shortage 2021-09-16 2024-03-18 145783
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-03-04 2022-03-24 156064
TEVA-CODEINE 15MG TABLET Resolved 2022-03-24 2022-05-19 157253
TEVA-OLANZAPINE 15MG TABLET Resolved 2022-06-03 2022-08-09 161955
TEVA-CODEINE 15MG TABLET Resolved 2022-07-25 2022-12-22 165444
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-08-18 2022-10-18 167182
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-12-01 2022-12-22 176821
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2023-02-09 2023-06-09 184225
TEVA-OLANZAPINE 15MG TABLET Resolved 2023-04-27 2023-06-21 190695
TEVA-CODEINE 15MG TABLET Resolved 2023-04-27 2023-06-09 190701
TEVA-PINDOLOL 15MG TABLET Resolved 2023-04-27 2023-07-05 190737
TEVA-AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2023-04-27 2023-08-18 190755
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-06-27 194125
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-06-16 2023-07-06 195036
TEVA-AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-16 2023-07-06 195130
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-06-21 195210
KOFFEX DM 15MG SYRUP Resolved 2023-06-16 2023-06-21 195231
TEVA-PINDOLOL 15MG TABLET Resolved 2023-06-19 2023-07-12 195533
BALMINIL DM (3MG/ML SUCROSE FREE) 15MG SYRUP Resolved 2023-06-19 2023-10-04 195560
KOFFEX DM (SUCROSE FREE) 15MG SYRUP Resolved 2023-06-19 2023-07-06 195640

Showing 841 to 860 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250